Author: admin

  • Lord Cashman – 2016 Parliamentary Question to the Department for International Development

    Lord Cashman – 2016 Parliamentary Question to the Department for International Development

    The below Parliamentary question was asked by Lord Cashman on 2016-03-23.

    To ask Her Majesty’s Government what assessment they have made of the benefits of including representatives from the Department for International Development in discussions and representation at the Global LGBTI Human Rights Conference that will take place in Uruguay from 13 to 15 July.

    Baroness Verma

    The UK will send a delegation to the Global LGBTI Human Rights Conference taking place in Montevideo in July. We are committed to working with those countries that will be represented at the conference, and others, to combat discrimination and violence against LGB&T people. This forms an important part of our wider international human rights work. DFID is assessing the benefits of including representatives from the department at the Global LGBTI Human Rights Conference through discussion with key lesbian, gay, bisexual and transgender (LGB&T) organisations and with other government departments. The Global LGBTI Human Rights Conference will provide an opportunity to share information, best practice and lessons learned with partners and to discuss how to better coordinate international efforts to support the promotion and protection of the rights of LGB&T people worldwide.

  • Lord Cashman – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    Lord Cashman – 2016 Parliamentary Question to the Foreign and Commonwealth Office

    The below Parliamentary question was asked by Lord Cashman on 2016-03-23.

    To ask Her Majesty’s Government what plans they have to support better co-ordination of financial and political support amongst governments and multilateral organisations in the advancement of the human rights of LGBTI people at the Global LGBTI Human Rights Conference that will take place in Uruguay from 13 to 15 July.

    Baroness Anelay of St Johns

    As I set out to the House of Lords on the 21 March, the UK will send a delegation to the Global Lesbian, Gay, Bisexual, Transgender and/or Intersex (LGBTI) Human Rights Conference taking place in Montevideo in July. We are committed to working with those countries that will be represented at the conference, and others, to combat discrimination and violence against LGBTI people. This forms an important part of our wider international human rights work.

    We continue to work through our Embassies and High Commissions and through international organisations, including the UN, EU, the Council of Europe and the Commonwealth, to promote general tolerance and non-discrimination toward LGBTI people and to address discriminatory laws, in particular those that criminalise homosexuality. The Global LGBTI Human Rights Conference will provide an opportunity to share information, best practice and lessons learned with partners and to discuss how to better coordinate international efforts and resources to support the promotion and protection of the rights of LGBTI people worldwide.

  • Lord Scriven – 2016 Parliamentary Question to the Department of Health

    Lord Scriven – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Scriven on 2016-03-23.

    To ask Her Majesty’s Government, further to the Written Answer by Lord Prior of Brampton on 23 March (HL6926), whether the issue of the sugar tax to be introduced by NHS England in their own premises by 2020 was raised as part of their conversations with NHS England, and if so, by whom and which ministers were consequently informed.

    Lord Prior of Brampton

    We have a range of conversations about key issues at Ministerial and official level with NHS England. NHS England is independent and the decision on a sugar levy on the National Health Service estate is a matter for them operationally. We are interested to see the results of their consultation on a sugar levy.

    The announcement of a soft drinks industry levy by the Chancellor in the Budget is the first step in our comprehensive Childhood Obesity Strategy, which will be launched in the summer, and gives companies strong incentives to reformulate their products.

  • Lord Scriven – 2016 Parliamentary Question to the Department of Health

    Lord Scriven – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Scriven on 2016-03-23.

    To ask Her Majesty’s Government, further to the Written Answer by Lord Prior of Brampton on 23 March (HL6926), on what date the Department of Health was informed that NHS England was going to introduce a sugar tax in NHS premises by 2020.

    Lord Prior of Brampton

    We have a range of conversations about key issues at Ministerial and official level with NHS England. NHS England is independent and the decision on a sugar levy on the National Health Service estate is a matter for them operationally. We are interested to see the results of their consultation on a sugar levy.

    The announcement of a soft drinks industry levy by the Chancellor in the Budget is the first step in our comprehensive Childhood Obesity Strategy, which will be launched in the summer, and gives companies strong incentives to reformulate their products.

  • Lord Mancroft – 2016 Parliamentary Question to the Department of Health

    Lord Mancroft – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Mancroft on 2016-03-23.

    To ask Her Majesty’s Government how many hepatitis C patients NHS England is planning to treat in 2016–17.

    Lord Prior of Brampton

    NHS England is planning to treat 10,000 patients with chronic hepatitis C in 2016/2017.

  • Lord Mancroft – 2016 Parliamentary Question to the Department of Health

    Lord Mancroft – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Mancroft on 2016-03-23.

    To ask Her Majesty’s Government for what reason NHS England intends to treat only a specified number of patients in 2016–17, as defined by recently published run rates for operational delivery networks services.

    Lord Prior of Brampton

    The National Institute for Health and Care Excellence (NICE) specifically requires Operational Delivery Networks (ODNs) to prioritise hepatitis C patients on the basis of highest unmet clinical need, as part of a progressive rollout of treatments over the next five years.

    NHS England is funding providers to double the number of patients treated and this number will ensure the National Health Service fully meets in 2016/17 the patient numbers NICE set out for progressive rollout of the treatments at the time it published its guidance.

    NHS England has invested in a Commissioning for Quality and Innovation scheme to incentivise ODNs to meet their agreed rate of roll-out. If their treatment rates deviate from this agreed rate of treatment, they are no longer eligible for these incentives.

    In meeting the obligations of its Mandate, NHS England has set out a planning approach for hepatitis C that delivers access to NICE recommended treatment without disinvestment in other health services.

  • Lord Mancroft – 2016 Parliamentary Question to the Department of Health

    Lord Mancroft – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Mancroft on 2016-03-23.

    To ask Her Majesty’s Government how many people diagnosed with hepatitis C are eligible for treatment under the National Institute for Health and Care Excellence guidance for new direct acting antiviral drugs.

    Lord Prior of Brampton

    Based on National Institute for Health and Care Excellence (NICE) modelling, NHS England has planned for 10,000 patients to be treated in 2016/17. No national registry exists for hepatitis C and as a result NICE estimates that the NHS should be treating 10,000 people based on the total number of people diagnosed with hepatitis C, their genotype, their treatment history and their disease severity, all of which impact on treatment eligibility.

  • Lord Mancroft – 2016 Parliamentary Question to the Department of Health

    Lord Mancroft – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Mancroft on 2016-03-23.

    To ask Her Majesty’s Government what plans they have to review their hepatitis C strategy in the light of other European countries’ strategies for tackling hepatitis C.

    Lord Prior of Brampton

    NHS England has been rapidly working on their plans for access to treatment during 2016/17 following enactment of the National Institute for Health and Care Excellence technical appraisal guidance and has committed to produce an operational framework for the treatment of hepatitis C during 2016/17. This will set out NHS England’s commitment to improving outcomes in hepatitis C across England.

  • Lord Mancroft – 2016 Parliamentary Question to the Department of Health

    Lord Mancroft – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Mancroft on 2016-03-23.

    To ask Her Majesty’s Government whether plans to introduce a hepatitis C improvement framework have been abandoned and, if so, why.

    Lord Prior of Brampton

    NHS England has been rapidly working on their plans for access to treatment during 2016/17 following enactment of the National Institute for Health and Care Excellence technical appraisal guidance and has committed to produce an operational framework for the treatment of hepatitis C during 2016/17. This will set out NHS England’s commitment to improving outcomes in hepatitis C across England.

  • Lord Mancroft – 2016 Parliamentary Question to the Department of Health

    Lord Mancroft – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Lord Mancroft on 2016-03-23.

    To ask Her Majesty’s Government what plans they have to ensure that the objectives of the hepatitis C improvement framework can still be achieved.

    Lord Prior of Brampton

    NHS England has been rapidly working on their plans for access to treatment during 2016/17 following enactment of the National Institute for Health and Care Excellence technical appraisal guidance and has committed to produce an operational framework for the treatment of hepatitis C during 2016/17. This will set out NHS England’s commitment to improving outcomes in hepatitis C across England.